HomeMIST • NASDAQ
add
Milestone Pharmaceuticals Inc
Previous close
$1.15
Day range
$1.12 - $1.25
Year range
$0.63 - $2.75
Market cap
65.23M USD
Avg Volume
1.56M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 20.52M | 95.90% |
Net income | -20.76M | -100.51% |
Net profit margin | — | — |
Earnings per share | -0.31 | -47.62% |
EBITDA | -20.50M | -96.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 55.96M | -37.46% |
Total assets | 61.88M | -35.54% |
Total liabilities | 68.01M | 21.27% |
Total equity | -6.12M | — |
Shares outstanding | 66.37M | — |
Price to book | -12.78 | — |
Return on assets | -74.69% | — |
Return on capital | -87.40% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -20.76M | -100.51% |
Cash from operations | -13.95M | -56.17% |
Cash from investing | 33.58M | 224.32% |
Cash from financing | 140.00K | -99.57% |
Net change in cash | 19.77M | 644.81% |
Free cash flow | -8.71M | -44.48% |
About
Founded
2003
Website
Employees
33